Home / Products / Formulations / Svizera Healthcare / Ace / FEMARELLE



  Each capsule of FEMARELLE contains approximately:
DT56a (tofu extract)…322 mg
Flaxseed…108 mg
  Therapeutic Indications & Usage
  FEMARELLE is advocated for managing postmenopausal symptoms and its complications.
  FEMARELLE is contraindicated in patients with known hypersensitivity to this product or any of its ingredients or soy. It is not meant for children, during pregnancy and lactation.
  Precaution & Warnings
  FEMARELLE is to be taken with care in those who are atopic genetically determined state of allergy to environmental allergens.

FEMARELLE should not be started in high doses in adult women with normal E2 levels all of a sudden especially if there are premalignant breast lesions. Post-puberty, FEMARELLE is recommended only after breast maturation has been attained.
  Adverse Reactions
  FEMARELLE has not been demonstrated to cause any significant adverse reactions. It does not affect the uterus as a whole, including its contractile activity. FEMARELLE does not increase levels of E2 or FSH either due to DT56a or flaxseed.
  Recommended Dosage & Administration
  Estrogen-depleted Female: 1 FEMARELLE Cap od / bid, with or without meals.

One FEMARELLE capsule could be adequate for menopausal symptoms, but for osteoporosis and cardiovascular benefits, two capsules daily are needed.

FEMARELLE need to be taken life-long, and must be combined with other low-risk dietary constituents and behaviors for the protective effects of phytoestrogens to be significantly manifest.
  FEMARELLE Capsules: Blister of 15 Capsules
"Maneesh" Pharmaceuticals   |  Manufacturing Excellence  |   International Presence  |  Products
"Maneesh" for Doctors  |  Our Team  |  For the Patients  
Contact Us  |  Feedback  |  Site Map  | Search Maneesh